Literature DB >> 21883128

A quality assurance programme for cell salvage in cardiac surgery.

A Kelleher1, S Davidson, M Gohil, M Machin, P Kimberley, J Hall, W Banya.   

Abstract

At the same time as cell salvage was introduced into our institution for all patients undergoing cardiac surgery with cardiopulmonary bypass, we established a supporting programme of quality assurance to reassure clinicians regarding safety and efficacy. Data collected in patients operated on between 2001 and 2007 included pre- and post-wash heparin concentration, haemoglobin concentration and free haemoglobin concentration. Cell salvage was used in 6826 out of a total of 7243 patients (94%). Post-wash heparin concentration was consistently low (always < 0.4 IU.ml(-1)). There was a significant decrease in post-wash haemoglobin concentration in 2003 compared to 2001, from a median (IQR [range]) of 19.6 (16.7-22.2 [12.9-25.5]) g.dl(-1) to 17.5 (13.6-20.8 [12.6-23.7]) g.dl(-1) (p < 0.015). In addition, there was a significant increase in free plasma haemoglobin in 2006 compared to 2001, from 0.5 (0.3-0.8 [0.1-2.6]) g.l(-1) to 0.8 (0.3-1.4 [0.3-5.2]) g.l(-1) (p < 0.001). This programme led to the detection of a change in operator behaviour in 2003 and progressive machine deterioration resulting in appropriate fleet replacement in 2006. You can respond to this article at http://www.anaesthesiacorrespondence.com.
© 2011 The Authors. Anaesthesia © 2011 The Association of Anaesthetists of Great Britain and Ireland.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21883128     DOI: 10.1111/j.1365-2044.2011.06862.x

Source DB:  PubMed          Journal:  Anaesthesia        ISSN: 0003-2409            Impact factor:   6.955


  3 in total

1.  Changes in mechanical fragility and free hemoglobin levels after processing salvaged cardiopulmonary bypass circuit blood with a modified ultrafiltration device.

Authors:  Sarah K Harm; Jonathan H Waters; Pamela Lynn; Robert Dyga; Jay S Raval; Ross F DiMarco; Mark H Yazer
Journal:  J Extra Corpor Technol       Date:  2012-03

Review 2.  [Cell salvage : Scientific evidence, clinical practice and legal framework].

Authors:  T Seyfried; E Hansen
Journal:  Anaesthesist       Date:  2019-02       Impact factor: 1.041

3.  Autologous blood salvage in cardiac surgery: clinical evaluation, efficacy and levels of residual heparin.

Authors:  Sérgio Domingos Vieira; Fernanda da Cunha Vieira Perini; Luiz Carlos Bento de Sousa; Enio Buffolo; Paulo Chaccur; Magaly Arrais; Fábio Biscegli Jatene
Journal:  Hematol Transfus Cell Ther       Date:  2019-11-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.